SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-278939
Filing Date
2023-11-16
Accepted
2023-11-16 17:13:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d561703d424b3.htm 424B3 328556
2 EX-FILING FEES d561703dexfilingfees.htm EX-FILING FEES 70567
3 GRAPHIC g561703g04y89.jpg GRAPHIC 22450
  Complete submission text file 0001193125-23-278939.txt   431687
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257883 | Film No.: 231415512
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 212-883-0200
Royalty Pharma Holdings Ltd. (Filer) CIK: 0001868134 (see all company filings)

IRS No.: 981526515 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257883-01 | Film No.: 231415513